期刊文献+

辛伐他汀依赖p53通路对K562细胞G_1期调节的分子机制

The molecular mechanism of regulation of G_1 phase in K562 cells treated with simvastatin in a p53 pathway-dependent manner
下载PDF
导出
摘要 目的探讨辛伐他汀体外处理后的K562细胞p53通路和K562细胞G1期的分子水平的变化,以说明辛伐他汀是否依赖p53通路参与K562细胞细胞周期G0/G1期停滞的调控和抑制K562细胞增殖。方法体外培养和用辛伐他汀处理K562细胞,用流式细胞术检测辛伐他汀作用后细胞周期和凋亡率的变化,用RT-PCR检测K562细胞p53通路和细胞周期G1期相关基因表达的变化。结果辛伐他汀能使K562细胞停滞在G0/G1期,明显诱导K562细胞凋亡,大多数p53通路基因和细胞周期相关基因的变化出现差异表达。结论辛伐他汀可能通过作用于参与细胞增殖和凋亡的p53通路,抑制K562细胞增殖并诱导细胞凋亡。 Objective To investigate the changes of p53 pathway and G1 phase in K562 cells after being treated with simvastatin in molecular levels, so as to illustrate whether simvastatin is involved in the regulation of G0/G1 arrest and inhibits the proliferation of K562 cells in a p53 pathway dependent-manner. Methods K562 ceils were cultured and treated with simvastatin in vitrol.The apoptosis rate and cell cycle of K562 cells were measured by flow cytometry(FCM) .The expression of p53 pathway and cell cycle were detected by RT-PCR at transcriptional level. Results We shown that G0/G1 arrest of cell cycle and significant apoptosis rate of K562 cells are induced by simvastatin. The most cell cycle related genes and genes of p53 pathway induced were expressed differentially in K562 cells. Conclusion Simvastatin can inhibit the proliferation of K562 cells and induce the apoptosis of K562 cells,depending on p53 pathway which is involved in cell proliferation and apoptosis.
出处 《四川医学》 CAS 2009年第3期312-315,共4页 Sichuan Medical Journal
关键词 K562细胞 P53通路 细胞周期 细胞周期相关基因 K562 cells p53 pathway cell cycle cell cycle related genes
  • 相关文献

参考文献10

  • 1Goldberg Z, Levav Y, Krichevsky S, et al. Treatment of chronic myeloid leukemia cells with imatinib (ST1571)impairs p53 accumulation in response to DNA damage [ J ]. Cell Cycle, 2004,3 ( 9 ) : 1188 - 1195
  • 2Di Bacco A, Keeshan K, McKenna SL, et al. Molecular abnormalities in chronic myetoid leukemia:deregulation of cell growth and apoptosis[J]. Oncologist, 2000,5 ( 5 ) : 405 - 415
  • 3任汉云,张念先,徐红,陆道培.胆固醇合成抑制剂辛伐他汀对K562细胞增殖和凋亡的作用[J].中华血液学杂志,2001,22(2):72-75. 被引量:14
  • 4McGahon A, Bissonnette R, Schmitt M, et cd. BCR/ABL maintains resistance of chronic myclogenous leukemia cells to apoptotic cell death [J] .Blood, 1994,83(5) : 1179 - 1187
  • 5Hoque A, Chen H,Xu XC. Statin induces apoptosis and cell growth arrest in prostate cancer cells[J]. Cancer Epidemiol Biomarkers Prey,2008,17 (1):88-94
  • 6Saito A, Saito N, Mol W, et al. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells [ J]. Melanoma Res,2008,18(2) :85 - 94
  • 7Mahdi T,Alcalay D,Cognard C, et al. Rescue of K562 cells from MDM2-modulated p53-dependent apoptosis by growth factor-induced differentiation[J]. Biol Cell, 1998,90 : 615 - 627
  • 8Alessandra Di Baeeo, Karen Kceshan, Sharon L, et al. Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis[ J]. Oneologist ,2000,5(5) :405 - 415
  • 9Wang W, Macaulay RJ. Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis[ J]. Can J Neurol Sci ,2003,30(4) :349 - 357
  • 10Maksimova E, Yie TA, Rom WN. In vitro mechanisms of lovastation on lung cancer cell lines as a potential chemopreventive agent[ J]. Lung, 2008, 186(1) :45 -54

二级参考文献10

  • 1Cuthbert JA,Lipsky PE.Regulation of proliferation and ras localization in transformed cells by products of mevalonate metabolism[].Cancer Research.1997
  • 2Carlberg M,Dricu A,Blegan H,et al.Mevalonic acid is limiting for Nlinked glycosylation and translocation of the insulin-like growth factor-I receptor to the cell surface[].Journal of Biological Chemistry.1996
  • 3Daley GQ,van Etten RA,Baltimore D.Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome[].Science.1990
  • 4Iwama A,Sawamura M,Nara Y,et al.Effect of lovastatin and fluromavalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF[].Clinical and Experimental Pharmacology and Physiology.1995
  • 5Dimitroulakos J,Nohynek D,Backway KL,et al.Increased sensitivity of acute myeloid leukemias to lovastatin-induced apoptosis: a potential therapeutic approach[].Blood.1999
  • 6Gibbs JB,Oliff A,Kohl NE.Farnesyltransferase inhibitors: ras research yields a potential cancer therapeutic[].Cell.1995
  • 7Lebowitz PF,Sakamura D,Prendergast GC.Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment[].Cancer Research.1997
  • 8Newman A,Clutterbuck RD,Powles RL,et al.Selective inhibition of primary myeloid leukemia cell growth by lovastatin[].Leukemia.1994
  • 9Cortez D,Stoica G,Dierce JH,et al.The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras dependent signaling pathway[].Oncegene.1996
  • 10McGahon A,Bissonnette R,Schmitt M,et al.BCR/ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death[].Blood.1994

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部